- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04463082
Non-invasive Assessment of the Current State of Hydration in Children by Ultrasound
December 6, 2022 updated by: University Hospital Ostrava
Assessment of the Current State of Volume Status in Children by Ultrasound Measurement of Vena Cava Inferior and Vena Jugularis Interna Combined With Passive Leg Raise: a Pilot Study
Children with clinical signs of severe dehydration will be examined by ultrasound in a supine position during admission.
Children aged between 1 and 15years will be divided into three weight groups: 10-20kg, 20-30kg, 30-50kg.
Early after admission 1st measurement of diameters of vena cava inferior (VCImax, VCImin) during breathing cycles and diameters of both venae jugulares (VJI dx max, min, VJI sin max, min) before and after passive leg raise maneuver will be recorded.
After a defined fluid infusion within 60 minutes, a second examination will be evaluated and compared with the first one.
The investigators considered also echocardiography to measure CO changes however they wanted to make it as simple as it might be at emergency during the night shift without an experienced cardiologist.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Only children admitted to the hospital with clinically detectable dehydration (weight loss, dry skin, sunken eyes, no tears) will be evaluated.
Weight, noninvasive blood pressure measurement, pulse rate will be recorded.
Measurements would be performed with an ultrasound probe with a low frequency (2-5 MHz), a curved array transducer will be used.
In the supine position, the ultrasound probe will be placed in the substernal area, in the longitudinal and transversal plane, 1 cm caudal to the confluence of the hepatic veins, and it will be operated in M-mode.
The largest (VCImax) and smallest (VCImin) diameters will be measured and the collapsibility index will be calculated (according to the formula: VCImax - VCI min / VCI max x100).
Immediately after this examination measurement of the right VJImax, min and the left VJImax, min will be measured again in the supine position, then after passive leg raise (lifting the lower limbs 45st.
for at least 1minute ) VJImax, min.
and left VJImax, min will be measured.
The collapsibility index for right and left VJI would be calculated according to the formula: VJImax - VJI min / VJI max x100.
After a defined fluid infusion (20ml/kg, but the maximum volume will be limited to 500ml, this means that over 25kg weight we would apply not more than 500ml) within 60 minutes.
A control examination of VCI, right VJI, and left VJI will be evaluated the same way as first and compared with the previous one.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Moravian-Silesian Region
-
Ostrava, Moravian-Silesian Region, Czechia, 70852
- University Hospital Ostrava
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 15 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- previously healthy children
- history and clinical signs of dehydration (gastroenteritis, diabetic ketoacidosis)
Exclusion Criteria:
- congenital heart diseases
- intestinal obstruction
- any signs of abdominal hypertension
- any illnesses known to affect the volume status
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Weight category 10-20kg
Pediatric patients with a weight of 10-20kg will be enrolled in this arm.
|
Intravenous administration of fluids (20ml/kg, but the maximum volume will be limited up to 500ml) within 60 minutes.
|
Experimental: Weight category 20-30kg
Pediatric patients with a weight of 20-30kg will be enrolled in this arm.
|
Intravenous administration of fluids (20ml/kg, but the maximum volume will be limited up to 500ml) within 60 minutes.
|
Experimental: Weight category 30-50kg
Pediatric patients with a weight of 30-50kg will be enrolled in this arm.
|
Intravenous administration of fluids (20ml/kg, but the maximum volume will be limited up to 500ml) within 60 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in vena cava inferior diameter pre- and post-hydration
Time Frame: 60 minutes
|
Change in vena cava inferior diameter (in millimetres) will be measured before and after hydration.
|
60 minutes
|
Change in vena jugularis interna diameter pre- and post-hydration (on the right side)
Time Frame: 60 minutes
|
Change in vena jugularis interna diameter (in millimetres) will be measured before and after hydration (on the right side).
|
60 minutes
|
Change in vena jugularis interna diameter pre- and post-hydration (on the left side)
Time Frame: 60 minutes
|
Change in vena jugularis interna diameter (in millimetres) will be measured before and after hydration (on the left side).
|
60 minutes
|
Change in collapsibility index pre- and post-hydration
Time Frame: 60 minutes
|
Change in collapsibility index values (in per cent) will be measured before and after hydration.
|
60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation to body surface area
Time Frame: 60 minutes
|
All obtained parameters from the other Outcome Measures will be correlated to the body surface area of the patient (measured in m2)
|
60 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tomáš Zaoral, MD,PhD, University Hospital Ostrava
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Unluer EE, Kara PH. Ultrasonography of jugular vein as a marker of hypovolemia in healthy volunteers. Am J Emerg Med. 2013 Jan;31(1):173-7. doi: 10.1016/j.ajem.2012.07.003. Epub 2012 Sep 11.
- Bauman Z, Coba V, Gassner M, Amponsah D, Gallien J, Blyden D, Killu K. Inferior vena cava collapsibility loses correlation with internal jugular vein collapsibility during increased thoracic or intra-abdominal pressure. J Ultrasound. 2015 Sep 18;18(4):343-8. doi: 10.1007/s40477-015-0181-2. eCollection 2015 Dec.
- Lu GP, Yan G, Chen Y, Lu ZJ, Zhang LE, Kissoon N. The passive leg raise test to predict fluid responsiveness in children--preliminary observations. Indian J Pediatr. 2015 Jan;82(1):5-12. doi: 10.1007/s12098-013-1303-5. Epub 2013 Dec 11.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2020
Primary Completion (Actual)
September 1, 2021
Study Completion (Actual)
October 1, 2021
Study Registration Dates
First Submitted
June 15, 2020
First Submitted That Met QC Criteria
July 7, 2020
First Posted (Actual)
July 9, 2020
Study Record Updates
Last Update Posted (Estimate)
December 7, 2022
Last Update Submitted That Met QC Criteria
December 6, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FNO-OPRIP-US-fluids
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
The investigators have no plan to share individual participant data with other researchers; the data will be provided upon a written request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastroenteritis
-
GlaxoSmithKlineCompletedRotavirus Gastroenteritis | Nosocomial Rotavirus Gastroenteritis
-
National Institute of Allergy and Infectious Diseases...Completed
-
Merck Sharp & Dohme LLCCompletedRotavirus Gastroenteritis
-
VaxartCompletedNorovirus GastroenteritisUnited States
-
VaxartCompletedNorovirus GastroenteritisUnited States
-
National Institute of Allergy and Infectious Diseases...WithdrawnGastroenteritis NorovirusUnited States
-
Merck Sharp & Dohme LLCCompletedRotavirus Gastroenteritis
-
Christian Medical College, Vellore, IndiaKarolinska InstitutetCompletedRotavirus GastroenteritisIndia
-
GlaxoSmithKlineCompletedRotavirus GastroenteritisBrazil
Clinical Trials on Intravenous administration of fluids
-
University of FoggiaUnknownHypothermia; AnesthesiaItaly
-
Samsung Medical CenterCompleted
-
University of Alabama at BirminghamRecruitingPediatric Lumbar PunctureUnited States
-
Ain Shams UniversityArmed Forces Hospitals, Southern Region, Saudi ArabiaCompletedPostoperative CareSaudi Arabia
-
MemorialCare Health SystemCompletedLength of Labor | Second Stage of Labor | Intravenous Hydration of LaborUnited States
-
University of Southern CaliforniaCompletedPancreatitisUnited States
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias AvanzadasCompletedAmyotrophic Lateral SclerosisSpain
-
University College, LondonCSL BehringUnknown
-
University of HawaiiUniversity of Washington; Society of Family PlanningCompletedHemorrhage | Blood Loss | Abortion | Dilation and EvacuationUnited States
-
Mt. Sinai Medical Center, MiamiFlorida Heart Research InstituteCompleted